Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
McKinsey
McKesson
Express Scripts
Medtronic

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

US Patent Family Members and Approved Drugs for Canada Patent: 2839805

See Plans and Pricing

« Back to Dashboard

US Patent Family Members and Approved Drugs for Canada Patent: CA2839805

These international patent data are derived from patent families, based on US drug-patent linkages. Accordingly, they should not be regarded as comprehensive records of ex-US drug-patent associations.
US Patent Number Estimated Patent Expiration Generic Name US Applicant US Tradename
  Start Trial 2031-08-01 interferon beta-1b Bayer Healthcare Pharms BETASERON
  Start Trial 2031-08-01 interferon beta-1a Biogen AVONEX
  Start Trial 2031-08-01 rituximab Genentech RITUXAN
  Start Trial 2031-08-01 infliximab Centocor Inc REMICADE
  Start Trial 2031-08-01 interferon beta-1a Serono Inc REBIF
>US Patent Number >Estimated Patent Expiration >Generic Name >US Applicant >US Tradename

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
McKinsey
Baxter
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.